In Salute. Epatite: un progetto in Burkina Faso per la lotta alla malattia

World Hepatitis day, our latest publication: Fewer complications and deaths: antiviral therapy is changing the course of HCV-related liver disease and cirrhosis. @UniPadova @RegioneVeneto @AisfFegato @WHO @EASLnews @AOPD @Epatite Read the full study:

📃We are proud to announce the 2024 Impact Factors for our journals: 🔵 Journal of Hepatology reaches a record 33.0, confirming its place as the leading journal in hepatology. 🟣 JHEP Reports achieves an impact factor of 7.5, firmly establishing itself among top publications in

Combined liver with other solid organ transplants: Promises, pitfalls ... https://t.co/u0I0dG2brB great collaboration between scientific societies: @EASLnews @AASLDtweets @_ILTS_

📢Our new Impact Factor is 33.0🎉 🥇Ranking number 1 in the Hepatology field once again! 👏Thanks to the Editorial Team, untiring peer reviewers & very innovative authors❕ @EASLnews @EASLedu #LiverTwitter

Great honour to take part as Easl GB representative in the preparation of the new EASL HBV guidelines! @EASLnews @EASLedu @CornbergMarkus @TestoniBarbara @wonglaihung

What a team! Thank you Grace, it was great working with you! @EASLnews @EASLedu

🍷🚫EASL will spotlight alcohol harm reduction at #EASLCongress 2025 with key events on 7–8 May, in collaboration with @WHO_Europe The Opening Ceremony on 7 May will feature public health leaders from Spain, Estonia, and WHO Europe. 🌷 On the same day, the #EASLStudio session

🌷"Missing #EASLCongress would mean missing the year's most transformative liver disease insights!" - says our EASL External Affairs Councillor @fprusso73 Our programme this year promises 5 days of cutting edge science, knowledge sharing, and engaging with the liver community

Somatic Copy Number Alterations in Circulating Cell-Free DNA as a Prognostic Biomarker for Hepatocellular Carcinoma: Insights from a Proof-of-Concept Study https://t.co/xKOF5nDA2R #mdpicancers via @Cancers_MDPI Thank you to all the collaborators! @ElisaPinto93 @stefanoindraccolo

Such an honor to host @SaSi_Lens in Padua for an insightful talk on #HBV! 🧬💡 Great discussions, valuable learnings, and amazing moments together 🙌 @fprusso73 @MartinaGambato @GiacomoGermani1 @UniPadova

🚨Due to high demand, onsite registration for the EASL #LiverCancerSummit 2025 is now at full capacity. 🚨 You can still participate online and gain full access to science, expert discussions and the latest advancements in the field. 🌎Engage with the full scientific programme

Great pleasure and honour to have Prof ⁦⁦@DebbieShawcros1⁩ in Padova for the Farini Meeting 2025! Thank you Debbie for joining us and for the amazing speech you gave on Gut Microbiota and Liver Disease! ⁦@EASLnews⁩ ⁦@UniPadova⁩ ⁦@OspedalePadova⁩

Amazing start at #Easl2025 SLD Summit in Estoril with SLD trajectories and end-points ⁦@AleksanderKrag⁩ ⁦@DebbieShawcros1⁩ ⁦@FrancqueSven⁩ ⁦@SagiZelber⁩ ⁦@MassimoPinzani⁩ @cyrielle.caussy ⁦@EASLnews⁩

🌟 New Release: The EASL Clinical Practice Guidelines for the Management of Patients with Decompensated Cirrhosis is now available on the EASL Guidelines App. Download today and access expert guidance at your fingertips! 📲 https://t.co/9sQiQrlbX4 @EASLNews @Jhepatology

It was great to have @MMendizabalMD in Padova! Great talk! Thanks for coming @UniPadova @alehlatam and see you in Amsterdam at the #EaslCongress 2025 @EASLnews

Don’t miss this opportunity! Register for #EASLCongress2025

Amazing news from Paul Brennan working with Stuart Forbes in Edinburgh, autologous macrophage therapy for liver cirrhosis! congratulations! Looking forward the next step…phase 3 trial? engineered macrophage??? @EdinUni_CRM @EASLnews @AisfFegato

You can’t miss this manuscript from @a_zanetto ..great work!

⏰The countdown is on! Make EASL #SLDSummit, on 23-25 January the first event you attend in 2025! This is your chance to dive into the latest research, clinical insights, and discussions shaping the future of steatotic liver disease. ✅ Learn from world-class experts ✅